Brief: Wanbury Receives Sertraline Form II Approval From Anvisa, Brazil
12/03/2026 03:57
March 12 (Reuters) - Wanbury Ltd WANB.NS: RECEIVES SERTRALINE FORM II APPROVAL FROM ANVISA, BRAZIL RECEIVES APPROVAL FOR SPECIAL GRADE METFORMIN Source text: ID:nBSE3w4BB Further company coverage: WANB.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Wanbury
See all newsBrief: Wanbury Ltd Receives 9 “No DMF Deficiency” Letters From USFDA For Metformin HCl
Brief: Wanbury Files New Drug Master File In South Africa For Tramadol Hcl API
Brief: Wanbury June-Quarter PAT 32.4 Million Rupees
Brief: Wanbury Receives No DMF Deficiency Letter From USFDA For Multiple Andas
Brief: Wanbury Says Completion Of US FDA Inspection At Tanuku Facility